Socioeconomic status and health disparities drive differences in accelerometer-derived physical activity in fatty liver disease and significant fibrosis
Fig 2
MVPA, LIPA and TLAC physical activity summaries by NAFLD (top panel) and significant fibrosis (bottom panel) status.
In panels A-F the Wilcoxon test showed a p-value < 0.001 indicating differences in physical activity between those who have NAFLD or fibrosis and those who do not have the disease.